ondansetron has been researched along with Pulsatile Tinnitus in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to assess the effect of ondansetron on symptoms of patients with subjective tinnitus accompanied by sensorineural hearing loss or normal hearing." | 9.17 | Ondansetron in patients with tinnitus: randomized double-blind placebo-controlled study. ( Fallah, AY; Hosseini, M; Modabbernia, A; Pourvaziri, A; Taslimi, N; Taslimi, S; Vahidi, H; Yazdani, N; Zarandi, MM, 2013) |
| "The aim of this study was to assess the effect of ondansetron on symptoms of patients with subjective tinnitus accompanied by sensorineural hearing loss or normal hearing." | 5.17 | Ondansetron in patients with tinnitus: randomized double-blind placebo-controlled study. ( Fallah, AY; Hosseini, M; Modabbernia, A; Pourvaziri, A; Taslimi, N; Taslimi, S; Vahidi, H; Yazdani, N; Zarandi, MM, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taslimi, S | 1 |
| Vahidi, H | 1 |
| Pourvaziri, A | 1 |
| Modabbernia, A | 1 |
| Fallah, AY | 1 |
| Yazdani, N | 1 |
| Taslimi, N | 1 |
| Hosseini, M | 1 |
| Zarandi, MM | 1 |
1 trial available for ondansetron and Pulsatile Tinnitus
| Article | Year |
|---|---|
Ondansetron in patients with tinnitus: randomized double-blind placebo-controlled study.
Topics: Adult; Aged; Anxiety; Depression; Double-Blind Method; Female; Hearing Loss, Sensorineural; Humans; | 2013 |